Abstract
Tinnitus could be a lucrative market for pharmaceutical companies: it is common, chronic and often crippling. Around 20% of the US and European population suffer from incessant ringing, buzzing, whistling and rustling in their ears at some point during their lives. Around a quarter of these seek medical help. But, until recently, doctors had little to offer, condemning many patients to insomnia, poor concentration and depression. In extreme cases, patients have committed suicide to escape the unrelenting noise. 1 However, studies published over the last year revolutionise our understanding of this disabling disease and raise the prospect of selective, effective treatments.
Additional information
1. Simpson JJ and Davies WE. Recent advances in the pharmacological treatment of tinnitus. Trends in Pharmacological Sciences 20: 12-17, 1999
Rights and permissions
About this article
Cite this article
Greener, M. New treatments tackle tinnitus. Inpharma Wkly. 1181, 3–4 (1999). https://doi.org/10.2165/00128413-199911810-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199911810-00004